Search clinical trials for: urinary micturition

Total 54010 results

Mansoura University

Not yet recruiting

Impact of Tadalafil 5 mg on Post-micturition Dribble in Young-age Men With no/Mild Lower Urinary Tract Symptoms

Lower Urinary Tract Symptoms

Egypt
Assistance Publique - Hôpitaux de Paris

Completed

Impact Evaluation of Different Micturition Modes on Patients With Medullar Injury of Quality of Life and Their Occupations (URO-ActSCi)

Micturition Disorder | Medullary Injury

France
Ankara City Hospital Bilkent

Completed

The Effect of Urinating Through the Zipper or by Pulling Down the Trousers on Uroflowmetry Parameters in LUTS

Urologic Diseases | Benign Prostatic Hyperplasia | Urinary Obstruction | Urinary Tract Disease | Micturition Disorder

Turkey
The Methodist Hospital Research Institute

Active, not recruiting

Mapping of the Human Brainstem During Continence and Micturition: Noninvasive 7-T fMRI Study

Healthy

United States
Bayer

Completed

Clinical Study to Evaluate the Treatment Effect and Safety of BAY1817080 in Patients With Overactive Bladder (OAB) (OVADER)

Overactive Bladder

Austria, Singapore, New Zealand, Australia, Portugal, Czechia, Poland, Germany, Sweden
St. Antonius Hospital Gronau

Completed

Postoperative Patient Comfort and Quality of Micturition in Suprapubic Tube vs. Transurethral Catheterization After RARP (MPH)

Prostate Cancer

Germany
Gérard Amarenco

Completed

Time to be Ready to Void: a New Tool to Assess the Time Needed to Perform Micturition in Multiple Sclerosis

Multiple Sclerosis | Gait Disorders, Neurologic | Urinary Incontinence, Urge

France
Velicept Therapeutics, Inc.

Completed

Evaluation of the Efficacy and Safety of Solabegron Tablets for Treatment of Overactive Bladder in Adult Women

Overactive Bladder

United States
Velicept Therapeutics, Inc.

Completed

A Study to Evaluate Once Daily Low Dose and High Dose Solabegron or Placebo Given for 12 Weeks to Treat Women With Symptoms of Overactive Bladder: Sudden Urge to Urinate, Frequent Urination Associated With Wetting Episodes (VEL-2001) (VEL-2001)

Overactive Bladder

United States
Astellas Pharma Europe B.V.

Completed

A Study to Evaluate the Efficacy, Safety and Tolerability of Mirabegron and Solifenacin Succinate Alone and in Combination for the Treatment of Overactive Bladder (Symphony)

Urologic Diseases | Urinary Bladder, Overactive | Urinary Bladder Diseases | Urological Manifestations | Signs and Symptoms

Belarus, Belgium, Czechia, Denmark, Finland, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Slovakia, Spain, Sweden, Ukraine, United Kingdom
EssaiClinique_PL-HPN

Unknown

Effect of Depletive Lumbar Puncture on Lower Urinary Tract Dysfunction in iNPH (PLHPN)

Normal Pressure Hydrocephalus

France
Coordinación de Investigación en Salud, Mexico

Unknown

Transobturator Subtrigonal Tape vs Transobturator Suburethral Tape for Stress Urinary Incontinence (S-TOTvsTOT)

Stress Urinary Incontinence

Mexico
University Hospital, Antwerp

Terminated

Comparative Study Between Bilateral and Unilateral Spinal Anaesthesia

Anesthesia; Adverse Effect, Spinal and Epidural

Belgium
Maastricht University Medical Center

Completed

Cohort Study: Perceptual Urge Sensation

Urinary Bladder, Overactive | Osteoporosis

Netherlands
Astellas Pharma Europe Ltd.

Completed

A Trial Comparing Combination Treatment (Solifenacin Plus Mirabegron) With One Treatment Alone (Solifenacin) (BESIDE)

Urologic Diseases | Urinary Bladder Diseases | Urinary Bladder Overactive

United States, Armenia, Australia, Austria, Belgium, Canada, Czechia, Denmark, Finland, France, Georgia, Germany, Greece, Hungary, Ireland, Israel, Italy, Lebanon, Netherlands, Norway, Poland, Portugal, Romania, Russian Federation, Slov... and more
Astellas Pharma Europe Ltd.

Completed

A Study to Evaluate the Efficacy and Safety of Mirabegron Compared to Solifenacin in Patients With Overactive Bladder Who Were Previously Treated With Another Medicine But Were Not Satisfied With That Treatment. (BEYOND)

Urologic Diseases | Urinary Bladder, Overactive | Urinary Bladder Diseases

Greece, Ireland, Armenia, Austria, Belarus, Belgium, Bulgaria, Canada, Czechia, Denmark, Finland, France, Georgia, Germany, Hungary, Italy, Kazakhstan, Latvia, Lebanon, Lithuania, Netherlands, Norway, Poland, Portugal, Russian Federation, Slovaki... and more
Astellas Pharma Inc

Completed

A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder (ARIES)

Urinary Bladder, Overactive

United States, Canada
Astellas Pharma Inc

Completed

Study to Assess the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder (SCORPIO)

Urinary Bladder, Overactive

Australia, Belgium, France, Spain, Sweden, Bulgaria, Romania, Italy, Greece, South Africa, Austria, Poland, United Kingdom, Hungary, Denmark, Netherlands, Switzerland, Ireland, Lithuania, Russian Federation, Germany, Latvia, Slovakia, Finlan... and more
Astellas Pharma Inc

Completed

Study to Test the Long Term Safety and Efficacy of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder (TAURUS)

Urinary Bladder, Overactive

Canada, Poland, Belgium, Spain, Sweden, United States, Romania, Italy, France, Austria, United Kingdom, Germany, Hungary, Australia, Denmark, Netherlands, Switzerland, Lithuania, Russian Federation, Latvia, South Africa, Slovakia, F... and more
Astellas Pharma Inc

Completed

A Study to Test the Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder (CAPRICORN)

Urinary Bladder, Overactive

United States, Hungary, Canada, Spain, Finland, Slovakia, Czechia, Sweden, Germany, Denmark, Norway
Astellas Pharma Europe B.V.

Completed

Study to Test the Efficacy and Safety of YM178 in Subjects With Symptoms of Overactive Bladder (Blossom)

Urinary Bladder, Overactive

Belgium, Czech Republic, Germany, Spain, Sweden, United Kingdom
Astellas Pharma Inc

Completed

A Study of YM178 in Subjects With Symptoms of Overactive Bladder

Urinary Bladder, Overactive

China, Taiwan, India, Korea, Republic of
Astellas Pharma Inc

Completed

A Study to Evaluate Safety and Efficacy of YM178 in Patients With Overactive Bladder

Urinary Bladder, Overactive

Japan
University Hospital, Ghent

Completed

Micturition Reeducation in Children With Cerebral Palsy

Daytime Urinary Incontinence

Belgium
University Hospital, Ghent

Completed

Prevalence of Incontinence and Risk Factors in Children With Cerebral Palsy

Urinary Incontinence

Belgium
Asan Medical Center
Astellas Pharma Korea, Inc.

Completed

Solifenacin Flexible Dosing Study in Frequent Micturition Patients With and Without Urgency

Overactive Bladder | Urinary Bladder, Overactive

Korea, Republic of
DongGuk University

Unknown

Serial Changes in Micturition Symptoms, Urine Flow and Bladder Voiding Efficiency Following Transobturator Tape Surgery

Stress Urinary Incontinence

Korea, Republic of
Children's Hospital, Dziekanów Leśny, Poland

Completed

Evaluation of Immunological Disorders of T Lymphocytes and Endocrinological Disorders as Pathogen Factors in Patients With Metaplasia of Urinary Bladder

The Follow-up Duration Was 1-8 Years. | The Main Reasons Behind Visiting the Hospital Were Recurrent Urinary Tract Infection, | Urinary Urgencies, Pollakiuria, Difficulty in Initiating Micturition, Pain in Hypogastrium, | Night Wetting and Day Wetting, Menstruation's Disorders, Urolithiasis... and other conditions

Poland
University Hospital Ostrava

Completed

Electronic Method for Recording Lower Urinary Tract Symptoms

Lower Urinary Tract Symptoms

Czech Republic
Lee's Pharmaceutical Limited
APOGEPHA Arzneimittel GmbH

Completed

Propiverine Hydrochloride Extended-Release Capsule for Overactive Bladder

Overactive Bladder

China
Astellas Pharma Inc
Astellas Pharma Indonesia Inc.

Completed

A Study to Evaluate Response of Overactive Bladder Symptom Score (OABSS) to Treatment (RESORT-2)

Overactive Bladder

Indonesia
Johannes Gutenberg University Mainz

Terminated

Effect of Desmopressin on the Nocturnal Micturition Frequency in Patients With Parkinson Disease (DEPOPA)

Parkinson Disease

Germany
Astellas Pharma Inc
Astellas Pharma Indonesia Inc.

Completed

Reproducibility Study of Overactive Bladder Symptom Score [OABSS] (RESORT-1)

Overactive Bladder

Indonesia
Kissei Pharmaceutical Co., Ltd.

Completed

A Confirmatory Study of KUC-7483 in Patients With Overactive Bladder

Overactive Bladder

Japan
Kissei Pharmaceutical Co., Ltd.

Withdrawn

Long-term Safety and Efficacy of KUC-7483 in Patients With Overactive Bladder

Overactive Bladder

Japan
University Hospital Inselspital, Berne

Completed

Does Thoracic Epidural Analgesia Influence Urinary Micturition by Patients Undergoing Thoracic Surgery?

Thoracotomy | Sternotomy

Switzerland
Kissei Pharmaceutical Co., Ltd.

Completed

A Phase II Study of KUC-7483 in Patients With Overactive Bladder

Overactive Bladder (OAB)

Japan
University Hospital, Ghent

Completed

Prevalence, Etiology and Therapy of Micturition Disorders of Children With a Mental and/or Motoric Disability

Micturition Disorder

Belgium
University Health Network, Toronto

Not yet recruiting

Adaptive Moderately Hypofractionated Post Operative Radiotherapy (AMPORA)

Post-Operative Prostate Cancer
Friends Research Institute, Inc.
Weill Medical College of Cornell University

Recruiting

Optimal Intervention to Full Viral Suppression: Text Me, Alexis!

HIV

United States
University of California, San Diego
National Institutes of Health (NIH)

Not yet recruiting

Phage Therapy for Recurrent UTIs in Kidney Transplant Recipients

Urinary Tract Infection, Recurrent
University College Dublin
St Vincent's University Hospital, Ireland; Mater Misericordiae University Hospital and other collaborators

Recruiting

The All Ireland Infectious Diseases Cohort Project (AIID)

Infectious Disease

Ireland
Lionel.D.Lewis, MD
Dartmouth Cancer Center

Not yet recruiting

HCQ in Resectable Localized Prostate Cancer

Resectable Localized Prostate Cancer
Bill & Melinda Gates Medical Research Institute

Not yet recruiting

Study To Evaluate Safety, Tolerability, and Pharmacokinetics of MAM01 in African Population

Healthy Volunteers

Kenya, Uganda
Assistance Publique - Hôpitaux de Paris
Institut Curie; Centre National de la Recherche Scientifique, France; Collège...

Not yet recruiting

Mechanics of Human Pre Implantation Development (MECANEMB)

Infertility
M.D. Anderson Cancer Center

Not yet recruiting

Endometrial Cancer, Risk Factors and Prevention Strategies: Perspectives of Patients and At-Risk Women

Endometrial Cancer

United States
University of Pennsylvania
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Not yet recruiting

APPLE: Aspirin to Prevent Pregnancy Loss and Preeclampsia (APPLE)

Pre-Eclampsia | Pregnancy Loss

United States
Rigshospitalet, Denmark

Not yet recruiting

Enhancing Lung Health in Kids With Structural Lung Damage and Malformations: a Randomized Controlled Trial on Azithromycin (AZI) for Airway Infection Prevention (TRALULALA-AZI)

Bronchiectasis | Tracheomalacia | BPD - Bronchopulmonary Dysplasia | Cystic Lung Disease | Vascular Ring | Chronic Atelectasis
Nazmy Edward Seif

Not yet recruiting

Mannitol Versus Nitroglycerin for Kidney Injury Prevention in Robotic-assisted Radical Prostatectomy or Cystectomy

Renal Impairment | Prostate Cancer | Surgery | Bladder Cancer | Renal Injury, Acute

Egypt
Maastricht University Medical Center
Jessa Hospital

Not yet recruiting

The Impact of Physical Activity Versus Dietary Energy Restriction on Tumour and Muscle Protein Synthesis in Prostate Cancer Patients (DIRECT)

Cancer of Prostate

Search clinical trials for: urinary micturition

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Djibouti

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations